Anamorelin: Ghrelin Receptor Agonism as a Potential Intervention for Osteosarcopenia

Journal Article Accepted manuscript Anamorelin: Ghrelin Receptor Agonism as a Potential Intervention for Osteosarcopenia Get access Palak Patadia, MD, Palak Patadia, MD Division of Endocrinology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana Search for other works by this author on: Oxford Academic Google Scholar Robert V Considine, PhD Robert V Considine, PhD Division of Endocrinology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana Corresponding author: Robert V Considine, PhD, Indiana University School of Medicine, 639 Barnhill Dr., Rm MS224B, Indianapolis, Indiana 46202, 317-278-2389, rconsidi@iu.edu https://orcid.org/0000-0002-5033-3642 Search for other works by this author on: Oxford Academic Google Scholar The Journal of Clinical Endocrinology & Metabolism, dgae043, https://doi.org/10.1210/clinem/dgae043 Published: 23 January 2024 Article history Received: 09 January 2024 Editorial decision: 13 January 2024 Accepted: 19 January 2024 Published: 23 January 2024